Related Experiment Video
Updated: May 19, 2026

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice
Published on: December 20, 2024
[Neuro-AIDS in the cART era]
1Neurologische Klinik, Medizinische Fakultät der Heinrich-Heine-Universität Düsseldorf, Moorenstrasse 5, Düsseldorf. Gabriele.Arendt@uniduesseldorf.de
Abstract:
After the introduction of antiretroviral combination therapy for the treatment of HIV infection in 1996 (highly active antiretroviral therapy = HAART, nowadays called combination antiretroviral therapy = cART), a steady decline in infection associated complications had been expected, especially with respect to central and peripheral nervous system manifestations. Until the beginning of the new millenium this hope came in fact true, but since then there has been a slow, but constant rise in the prevalence, and later on also in the incidence of directly virus-associated neurological complications in HIV infected patients. HIV-associated diseases that neurologists might see in their routine work include HIV-associated dementia (HAD) and its precursor stages, HIV-associated myelopathy, HIV-associated polyneuropathies and myopathies as well as the opportunistic brain infections and immune reconstitution phenomena (IRIS). This article describes practical diagnostic procedures according to the guidelines of the German Neurological Society and the respective therapeutic options.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Drugs Affecting Neurotransmitter Synthesis
Arboviral Encephalitis
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Drugs Affecting Neurotransmitter Release or Uptake

